Moreover, consistent with the CD4+ T cell pSTAT5 levels, the CLL patients treated with CIT also displayed higher levels of Ki-67 expressing aTregs (Figure 4E) and Tcons (Supplementary Figure S5B) compared to patients treated with BTKi. This evidence concerns the gene CD4 and B-cell chronic lymphocytic leukemia.